Table 1.
Liver disease | Liver status | % per year | References |
---|---|---|---|
HBV | Noncirrhosis | 0.4–0.6 | Yang et al.6 |
Cirrhosis | 2.6–6.0 | Ioannou et al.7; Beasley et al.8 | |
HCV | Noncirrhosis | 0.1 | Yoshida et al.9 |
Cirrhosis | 3.0–8.0 | Ioannou et al.7; Sangiovanni et al.10; Lok et al.11 | |
ALD | Cirrhosis | 2.6–6.8 | Mancebo et al.12; Nahon et al.13 |
Haemochromatosis | Cirrhosis | 5.0 | Deugnier et al.14; Fracanzani et al.15 |
AILD | Cirrhosis | 0.2–1.8 | Tansel et al.16; Trivedi et al.17 |
NASH | Cirrhosis | 2.6 | Schlesinger et al.18; Calle et al.19; Younossi et al.20 |
AILD, autoimmune liver diseases; ALD, alcohol liver disease; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; NASH, nonalcoholic steatohepatitis.